Related Links Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Study of a Multi-Modal Screening Strategy for the Early Detection of Lung Cancer in Current or Former Smokers

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs No phase specified Health services research, Screening Active 50 to 75 Other BCCA-H08-01132 H08-01132, NCT00751660

Trial Description

Purpose:

Screening may help doctors find lung cancer sooner, when it may be easier to treat.

This clinical trial is studying screening methods to see how well they find lung cancer early in current or former smokers.

Eligibility:

Eligibility criteria include the following:

• 50-75 years old
• Currently smokes or stopped smoking no more than 14 years ago
• More than 2 years since chest CT scan
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Participants will have their lung function tested at the beginning of the study. They will also undergo a spiral CT scan at the beginning of the study and at 1 and 2 years. Some participants will undergo an additional CT scan at 3 months. Some participants will also undergo bronchoscopy and bronchial biopsies.

Participants will undergo blood sample collection periodically for laboratory studies at the beginning of the study and at least once a year for 2 years.

Participants will fill out questionnaires on smoking, work exposure, family history, medical information, quality of life, and anxiety at the beginning of the study and every 6 months for up to 2 years.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

British Columbia Cancer Agency - Vancouver Cancer Centre

Stephen Lam, MD, Principal investigator		Ph: 604-675-8089; 800-663-3333

Canada
Alberta
	Calgary
	University of Calgary Health Sciences Centre
		Contact Person	Ph:  403-944-1744
British Columbia
	Vancouver
	British Columbia Cancer Agency - Vancouver Cancer Centre
		Stephen Lam, MD	Ph:  604-675-8089 800-663-3333
Nova Scotia
	Halifax
	Nova Scotia Cancer Centre
		Contact Person	Ph:  902-473-1913
Ontario
	Hamilton
	Margaret and Charles Juravinski Cancer Centre
		Contact Person	Ph:  905-387-9495 1-866-966-5864
	Toronto
	Princess Margaret Hospital
		Contact Person	Ph:  416-946-4501 ext 6318
Quebec
	Quebec
	L'Hopital Laval
		Contact Person	Ph:  418-656-4810

Registry Information
Official Title		Early Detection of Lung Cancer - A Pan Canadian Study
Trial Start Date		2008-09-17
Trial Completion Date		2013-03-01 (estimated)
Registered in ClinicalTrials.gov		NCT00751660
Date Submitted to PDQ		2008-09-03
Information Last Verified		2008-12-14